1. 0521 Daridorexant (ACT-541468), A Dual Orexin Receptor Antagonist for the Treatment of Insomnia Disorder: Double Blind, Randomized, Phase 3 Studies for Efficacy and Safety in Adult and Elderly Patients. (27th May 2020) Authors: Zammit, G; Seboek Kinter, D; Bassetti, C; Leger, D; Hermann, V; Pain, S; Roth, T Journal: Sleep Issue: Volume 43(2020)Supplement 1 Page Start: A199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗